Minocycline to Treat Amyotrophic Lateral Sclerosis
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to test the safety, tolerability, and effectiveness of
minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)